These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17158047)

  • 1. Quantitative structure-activity relationship (QSAR) of tacrine derivatives against acetylcholinesterase (AChE) activity using variable selections.
    Jung M; Tak J; Lee Y; Jung Y
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1082-90. PubMed ID: 17158047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues.
    Recanatini M; Cavalli A; Belluti F; Piazzi L; Rampa A; Bisi A; Gobbi S; Valenti P; Andrisano V; Bartolini M; Cavrini V
    J Med Chem; 2000 May; 43(10):2007-18. PubMed ID: 10821713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of therapeutic potency of tacrine derivatives as BuChE inhibitors from quantitative structure-activity relationship modelling.
    Bitam S; Hamadache M; Hanini S
    SAR QSAR Environ Res; 2018 Mar; 29(3):213-230. PubMed ID: 29390887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
    J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
    El-Malah A; Gedawy EM; Kassab AE; Salam RM
    Arch Pharm (Weinheim); 2014 Feb; 347(2):96-103. PubMed ID: 24343873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions.
    Carlier PR; Chow ES; Han Y; Liu J; El Yazal J; Pang YP
    J Med Chem; 1999 Oct; 42(20):4225-31. PubMed ID: 10514292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homodimeric tacrine congeners as acetylcholinesterase inhibitors.
    Hu MK; Wu LJ; Hsiao G; Yen MH
    J Med Chem; 2002 May; 45(11):2277-82. PubMed ID: 12014965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Biological Evaluation of New Tacrine Analogues under Microwave Irradiation.
    Alshareef HF; Mohamed HAEH; Salaheldin AM
    Chem Pharm Bull (Tokyo); 2017; 65(8):732-738. PubMed ID: 28768927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties.
    Rodríguez-Franco MI; Fernández-Bachiller MI; Pérez C; Hernández-Ledesma B; Bartolomé B
    J Med Chem; 2006 Jan; 49(2):459-62. PubMed ID: 16420031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three Dimensional Quantitative Structure Activity Relationship and Pharmacophore Modeling of Tacrine Derivatives as Acetylcholinesterase Inhibitors in Alzheimer's Treatment.
    Ansari F; Ghasemi JB; Niazi A
    Med Chem; 2020; 16(2):155-168. PubMed ID: 31092184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
    Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
    Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel tacrine derivatives exhibiting improved acetylcholinesterase inhibition: Design, synthesis and biological evaluation.
    Reddy EK; Remya C; Mantosh K; Sajith AM; Omkumar RV; Sadasivan C; Anwar S
    Eur J Med Chem; 2017 Oct; 139():367-377. PubMed ID: 28810188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, acetylcholinesterase inhibition and neuroprotective activity of new tacrine analogues.
    León R; Marco-Contelles J; García AG; Villarroya M
    Bioorg Med Chem; 2005 Feb; 13(4):1167-75. PubMed ID: 15670925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrine based human cholinesterase inhibitors: synthesis of peptidic-tethered derivatives and their effect on potency and selectivity.
    Butini S; Guarino E; Campiani G; Brindisi M; Coccone SS; Fiorini I; Novellino E; Belinskaya T; Saxena A; Gemma S
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5213-6. PubMed ID: 18786825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonism.
    Lange JH; Coolen HK; van der Neut MA; Borst AJ; Stork B; Verveer PC; Kruse CG
    J Med Chem; 2010 Feb; 53(3):1338-46. PubMed ID: 20047331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues.
    Marco JL; de los Ríos C; Carreiras MC; Baños JE; Badía A; Vivas NM
    Bioorg Med Chem; 2001 Mar; 9(3):727-32. PubMed ID: 11310608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
    Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer's disease.
    Mao F; Li J; Wei H; Huang L; Li X
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):995-1001. PubMed ID: 25792506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.